001     282331
005     20251120152542.0
024 7 _ |a 10.1007/s00702-025-02982-4
|2 doi
024 7 _ |a pmid:40986033
|2 pmid
024 7 _ |a 0375-9245
|2 ISSN
024 7 _ |a 0022-3026
|2 ISSN
024 7 _ |a 0300-9564
|2 ISSN
024 7 _ |a 1435-1463
|2 ISSN
037 _ _ |a DZNE-2025-01292
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Poplawska-Domaszewicz, Karolina
|b 0
245 _ _ |a Management of neuropsychiatric, motor and non-motor symptoms in Parkinson´s disease after long distance air travel: a consensus view.
260 _ _ |a Wien [u.a.]
|c 2025
|b Springer
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1763648586_2193
|2 PUB:(DE-HGF)
|x Review Article
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a High altitude airline travel can have various effects on health in normal subjects. The effect of airline long distance travelling at high altitude on Parkinson's disease is not clearly known, and occasional reports suggest that after long-haul flights parkinsonian motor and aspects of nonmotor states may worsen temporarily. Worsening of parkinsonian state may be linked to air travel related dehydration, hypoxic effect of decreased oxyhaemoglobin saturation, jet lag, alteration in timing of drug intake as well as potential effect on sleep wake cycle and autonomic dysfunction causing syncope. Although symptoms are generally reversible, appropriate pre-travel planning, personalized to Parkinson's disease subtype and disease, is essential to mitigate risks. Here, we provide an evidence-based overview of challenges and management strategies for Parkinson's disease patients undertaking long-distance air travel.
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a Airline travel
|2 Other
650 _ 7 |a Dehydration
|2 Other
650 _ 7 |a Hypoxia
|2 Other
650 _ 7 |a Nonmotor
|2 Other
650 _ 7 |a Parkinson’s disease
|2 Other
650 _ 7 |a Syncope
|2 Other
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Parkinson Disease: therapy
|2 MeSH
650 _ 2 |a Parkinson Disease: complications
|2 MeSH
650 _ 2 |a Parkinson Disease: physiopathology
|2 MeSH
650 _ 2 |a Air Travel
|2 MeSH
650 _ 2 |a Consensus
|2 MeSH
700 1 _ |a Kaasinen, Valtteri
|b 1
700 1 _ |a van der Plas, Anton Adriaan
|b 2
700 1 _ |a Barbosa, Pedro Melo
|b 3
700 1 _ |a Heim, Beatrice
|b 4
700 1 _ |a Slawek, Jaroslaw
|b 5
700 1 _ |a Falup-Pecurariu, Cristian
|b 6
700 1 _ |a Pirtosek, Zvezdan
|b 7
700 1 _ |a Storch, Alexander
|0 P:(DE-2719)9000306
|b 8
|u dzne
700 1 _ |a Chen, Rosabel
|b 9
700 1 _ |a Schröter, Nils
|b 10
700 1 _ |a Jost, Wolfgang H
|b 11
700 1 _ |a Chaudhuri, K Ray
|b 12
773 _ _ |a 10.1007/s00702-025-02982-4
|g Vol. 132, no. 11, p. 1699 - 1703
|0 PERI:(DE-600)1481655-6
|n 11
|p 1699 - 1703
|t Journal of neural transmission
|v 132
|y 2025
|x 0375-9245
856 4 _ |u https://pub.dzne.de/record/282331/files/DZNE-2025-01290_Restricted.pdf
856 4 _ |u https://pub.dzne.de/record/282331/files/DZNE-2025-01290_Restricted.pdf?subformat=pdfa
|x pdfa
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 8
|6 P:(DE-2719)9000306
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
915 _ _ |a DEAL Springer
|0 StatID:(DE-HGF)3002
|2 StatID
|d 2025-01-02
|w ger
915 _ _ |a DEAL Springer
|0 StatID:(DE-HGF)3002
|2 StatID
|d 2025-01-02
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2025-01-02
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b J NEURAL TRANSM : 2022
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2025-01-02
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2025-01-02
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2025-01-02
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2025-01-02
920 1 _ |0 I:(DE-2719)5000014
|k AG Storch
|l Non-Motor Symptoms in Parkinson's disease
|x 0
980 _ _ |a journal
980 _ _ |a EDITORS
980 _ _ |a VDBINPRINT
980 _ _ |a I:(DE-2719)5000014
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21